Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Cholestyramine in the Management of Hyperphosphatemia in Adult Hemodialysis Patients

NCT05577507 is registered in ClinicalTrials.gov with Ain Shams University as lead sponsor.

NCT NCT05577507
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05577507 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Cholestyramine in the Management of Hyperphosphatemia in Adult Hemodialysis Patients
Lead sponsor
Ain Shams University
Phase
Phase 4
Overall status
Completed
Start date
March 30, 2023
Completion date
June 30, 2023
Enrollment
80 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney diseases, hemodialysis complication, hyperphosphatemia